| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-05 |